A Pilot, Open-Label, Randomized, Crossover, Pharmacokinetic Study Of Enhanced Bioavailability Celecoxib Formulations D1, D2 And D3 In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 20 Aug 2010
At a glance
- Drugs Celecoxib (Primary)
- Indications Arthritis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 09 Dec 2009 Additional location (USA) identified as reported by ClinicalTrials.gov
- 26 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Aug 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.